Skip to main content

Table 1 Patient characteristics

From: Effect of cryoprecipitate on an increase in fibrinogen level in patients with excessive intraoperative blood loss: a single-center retrospective study

 

Group A

(n = 36)

Group B

(n = 37)

Group C

(n = 11)

p

Age (years)

62 ± 14

61 ± 18

67 ± 19

0.34

Sex (male/female)

20/16

26/11

6/5

0.37

Height (cm)

157 ± 0

160 ± 8

158 ± 7

0.25

Weight (kg)

55 ± 14

63 ± 12*

60 ± 11

0.048

ASA-PS, 1/2/3/1E/2E/3E/4E

0/2/18/0/2/13/1

0/10/16/0/1/6/4

0/3/6/1††/0/0/1

0.02

Surgery

 Cardiovascular/obstetric/other

33/2/1

30/4/3

8/2/1

0.55

Operation time (min)

426 ± 148

533 ± 212

660 ± 266**

0.002

Anesthesia time (min)

527 ± 174

643 ± 254

774 ± 307**

0.006

Intraoperative blood loss (ml)

3,348 ± 791

6,688 ± 1,225**

14,281 ± 5,142**

< 0.001

Cryoprecipitate, 2/4/6 packs

33/3/0

34/2/1

7††/4††/0

0.04

  1. ASA-PS American Society of Anesthesiologists physical status classification
  2. *p < 0.05 vs. Group A, **p < 0.01 vs. Group A, p < 0.05 vs. expected value, ††p < 0.01 vs. expected value